openPR Logo
Press release

Artificial Intelligence (AI) in Life Sciences Market Size is Projected to Reach US$ 15.4 Billion by 2032, Growth Rate (CAGR) of 22.4%

02-09-2024 08:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: IMARC Group

Artificial Intelligence (AI) in Life Sciences Market

Artificial Intelligence (AI) in Life Sciences Market

IMARC Group's report titled "Artificial Intelligence in Life Sciences Market Report by Offering (Software, Hardware, Services), Deployment (On-premises, Cloud-based), Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring), and Region 2024-2032". The global artificial intelligence in life sciences market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.4 Billion by 2032, exhibiting a growth rate (CAGR) of 22.4% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artificial-intelligence-in-life-sciences-market/requestsample

Factors Affecting the Growth of Artificial Intelligence in Life Sciences Industry:

• Advancements in Drug Discovery and Development:

In the realm of drug discovery and development, AI has become a game-changer. Pharmaceutical companies and research institutions are harnessing the power of AI to streamline and accelerate this complex process. AI-driven algorithms are capable of analyzing vast datasets with unprecedented speed and precision. They can identify potential drug candidates by scanning existing scientific literature, patents, and clinical trial data. Moreover, AI can predict the efficacy and safety of these candidates, enabling researchers to prioritize the most promising ones for further study. One notable application is virtual drug screening, where AI models simulate interactions between drug compounds and biological targets. This approach dramatically reduces the time and cost traditionally associated with identifying potential drug candidates. Additionally, AI aids in optimizing clinical trial designs by identifying patient populations most likely to respond positively to a particular treatment, thus increasing the likelihood of successful drug launches.

• Personalized Medicine and Patient Care:

Personalized medicine has emerged as a transformative trend in healthcare, and AI is at its core. Healthcare providers are now equipped with AI-powered tools that analyze the comprehensive data of a patient, including genomic information, medical history, lifestyle choices, and even real-time health metrics. This wealth of information allows for the tailoring of treatment plans to individual patients. AI-driven diagnostics help healthcare professionals make quicker and more accurate diagnoses, leading to earlier interventions and improved patient outcomes. Moreover, predictive analytics can identify potential health risks and suggest preventive measures. In the field of oncology, AI assists in selecting the most effective cancer treatments based on the genetic profile of a patient, increasing the chances of successful outcomes and minimizing side effects.

• Data-Driven Research and Decision-Making:

Data is the lifeblood of the life sciences industry, and AI is instrumental in harnessing its full potential. With the exponential growth of healthcare data, traditional methods of analysis have become inadequate. AI, particularly machine learning, excels at handling and interpreting large and complex datasets. Researchers can employ AI to discover hidden patterns, relationships, and biomarkers within data, aiding in the identification of novel therapeutic targets or disease mechanisms. Additionally, AI algorithms can predict disease outbreaks by analyzing epidemiological data, helping public health officials take proactive measures. In clinical settings, AI supports evidence-based decision-making by providing real-time insights into patient conditions, enabling healthcare providers to make more informed choices regarding treatments and interventions.

Leading Companies Operating in the Global Artificial Intelligence in Life Sciences Industry:

• AiCure LLC
• Apixio Inc. (Centene Corporation)
• Atomwise Inc
• Enlitic Inc.
• International Business Machines Corporation
• Insilico Medicine Inc.
• Nuance Communications Inc.
• NuMedii Inc.
• Sensely Inc.
• Sophia Genetics SA

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-intelligence-in-life-sciences-market

Artificial Intelligence in Life Sciences Market Report Segmentation:

By Offering:

• Software
• Hardware
• Services

Software dominates the market as it encompasses a wide range of AI applications, from drug discovery algorithms and electronic health record systems to predictive analytics and personalized treatment planning tools, making it a fundamental driver of innovation and efficiency within the life sciences industry.

By Deployment:

• On-premises
• Cloud-based

Cloud-based holds maximum number of shares due to its scalability, cost-efficiency, and accessibility, making it a preferred choice for organizations seeking flexible and convenient solutions for their AI applications.

By Application:

• Drug Discovery
• Medical Diagnosis
• Biotechnology
• Clinical Trials
• Precision and Personalized Medicine
• Patient Monitoring

Drug discovery represents the largest segment due to its crucial role in revolutionizing the pharmaceutical industry, where AI-driven advancements significantly reduce development time and costs while enhancing the discovery of novel therapeutic compounds.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the artificial intelligence in life sciences market is attributed to its robust infrastructure for research and development, significant investments in AI technology, and a well-established healthcare ecosystem that fosters the adoption of AI in the life sciences sector.

Global Artificial Intelligence in Life Sciences Market Trends:

AI is enabling the identification of new therapeutic uses for existing drugs, a process known as drug repurposing. By analyzing vast datasets on drug interactions, molecular pathways, and disease mechanisms, AI can pinpoint potential candidates for repurposing. This approach accelerates drug development and also reduces risks and costs associated with bringing new treatments to market.

Additionally, in the field of medical imaging, AI is revolutionizing diagnostics. Machine learning algorithms can analyze medical images, such as MRIs, CT scans, and X-rays, with remarkable accuracy. This assists radiologists and pathologists in detecting abnormalities, tumors, and other health issues at an earlier stage, leading to more timely interventions and improved patient outcomes.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) in Life Sciences Market Size is Projected to Reach US$ 15.4 Billion by 2032, Growth Rate (CAGR) of 22.4% here

News-ID: 3378966 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for Artificial

Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences. As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making. Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc. The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs. Artificial organs are surgically implanted or are extra
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for